[Pharmaceutical evaluation of a hollow type suppository. II. Indomethacin added form and release characteristics of the hollow type suppository]. 1985

Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
May 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
March 1985, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
June 1991, Chemical & pharmaceutical bulletin,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
August 1982, Journal of pharmaceutical sciences,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
November 1986, Drug design and delivery,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
December 1986, Journal of pharmacobio-dynamics,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
January 1983, Annales pharmaceutiques francaises,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
August 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
July 2003, Farmaco (Societa chimica italiana : 1989),
Y Watanabe, and K Yokoyama, and M Yamaji, and F Tanaka, and M Matsumoto
January 1971, Reumatismo,
Copied contents to your clipboard!